ARTICLE | Targets & Mechanisms
Unsaturated remyelination
Case Western spins out Convelo to develop remyelination drugs
August 17, 2018 1:46 AM UTC
Enzymes downstream in cholesterol biosynthesis could provide new ways to stimulate remyelination that avoid the baggage of previously identified multiple sclerosis targets, according to a group at Case Western. The university is spinning out Convelo Therapeutics Inc. to translate the idea.
Marketed therapies for MS work via immune suppression, which slows disease progression but does not regenerate lost myelin. ...